NCT02110459View on ClinicalTrials.gov

Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Renal Impairment

Interventions

DRUG

POL7080

Intravenous infusion

Trial Locations (1)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Polyphor Ltd.

INDUSTRY